Australija - engleski - Department of Health (Therapeutic Goods Administration)

servier laboratories (australia) pty ltd - indapamide hemihydrate; perindopril arginine -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

servier laboratories (australia) pty ltd - gliclazide -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

servier laboratories (australia) pty ltd - fotemustine -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

servier laboratories (australia) pty ltd - indapamide hemihydrate -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

servier laboratories (australia) pty ltd - indapamide hemihydrate -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

servier laboratories (australia) pty ltd - strontium ranelate -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

servier laboratories (australia) pty ltd - perindopril arginine; amlodipine besylate -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

servier laboratories (australia) pty ltd - agomelatine -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - indapamide hemihydrate, quantity: 0.625 mg; perindopril arginine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; maltodextrin; magnesium stearate; colloidal anhydrous silica; macrogol 6000; lactose monohydrate; colour - treatment of hypertension.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - tipiracil hydrochloride, quantity: 7.065 mg; trifluridine, quantity: 15 mg - tablet, film coated - excipient ingredients: carnauba wax; pregelatinised maize starch; lactose monohydrate; iron oxide yellow; titanium dioxide; macrogol 8000; indigo carmine aluminium lake; hypromellose; stearic acid; iron oxide red; shellac; purified talc; magnesium stearate - colorectal cancer lonsurf is indicated for the treatment of adult patients with metastatic colorectal cancer (mcrc) who have been previously treated with, or are not considered candidates for fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti-egfr agents.,gastric cancer lonsurf is indicated for the treatment of adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, her2/neu-targeted therapy.